ライフサイエンスコーパス: end-of-life care

1 the complex communication necessary for good end of life care.

2 ly when hospital admissions occur as part of end of life care.

3 tive intervention to palliation and finally, end of life care.

4 t discussing their wishes or preferences for end of life care.

5 ness has not been elaborated with respect to end of life care.

6 sion and anxiety, illness understanding, and end-of-life care.

7 lth professional attitudes to palliative and end-of-life care.

8 patients with DT-LVAD are receiving optimal end-of-life care.

9 cancer pain and no evidence of palliative or end-of-life care.

10 nto survivorship, and metastatic disease and end-of-life care.

11 ared follow-up and survivorship care, and in end-of-life care.

12 s importance for patient comfort and optimal end-of-life care.

13 unit culture committed to dignity-conserving end-of-life care.

14 sing use of hospice did not offset intensive end-of-life care.

15 rences in disease trajectories and access to end-of-life care.

16 cation of death is an important component of end-of-life care.

17 ory determination of death and its impact on end-of-life care.

18 ulatory determination of death could improve end-of-life care.

19 ractitioners is vital to ensure high quality end-of-life care.

20 elated and addictive disorders as well as in end-of-life care.

21 to hospice services, key measures of quality end-of-life care.

22 s frequently misconstrued as synonymous with end-of-life care.

23 ative practitioners to provide comprehensive end-of-life care.

24 s of healthcare and improving the quality of end-of-life care.

25 ny are uncertain of the practice's impact on end-of-life care.

26 r declines in the patient's health and their end-of-life care.

27 ansplant process might relate to patterns of end-of-life care.

28 hosocial issues (including carer issues) and end-of-life care.

29 receipt of life-sustaining interventions and end-of-life care.

30 ere has been extensive political debate over end-of-life care.

31 e associated with markers of poor quality in end-of-life care.

32 ning Treatment) forms are a major advance in end-of-life care.

33 dy outcome was participants' preferences for end-of-life care.

34 MCS, achieving optimal device settings, and end-of-life care.

35 d similar physician and hospital patterns of end-of-life care.

36 nterventions to improve important aspects of end-of-life care.

37 e similar physician and hospital patterns of end-of-life care.

38 We excluded patients receiving end-of-life care.

39 well: Organ donation is an important part of end-of-life care.

40 may not fit with a family's preferences for end-of-life care.

41 cer where it is correlated with high-quality end-of-life care.

42 -beating donors, unless specialty trained in end-of-life care.

43 nating OR staff concerns about their role in end-of-life care.

44 of administrative models of care delivery on end-of-life care.

45 rders, advance directives, or are in need of end-of-life care.

46 o the ICU to incorporate organ donation into end-of-life care.

47 fied as one of the most important factors in end-of-life care.

48 ospital services, and an increasing need for end-of-life care.

49 re has sometimes come at the expense of good end-of-life care.

50 may have diverse preferences that influence end-of-life care.

51 t differences in the use of life support and end-of-life care.

52 since immigration, and region of birth, with end-of-life care.

53 ed care planning, and timely patient-centred end-of-life care.

54 minants have created widening disparities in end-of-life care.

55 had focused on patients during treatment and end-of-life care.

56 life support utilization and the quality of end-of-life care.

57 r to assist them in discussing prognosis and end-of-life care.

58 sider spirituality an important dimension of end-of-life care.

59 d whether these potential disparities modify end-of-life care.

60 r-reported quality rating of "excellent" for end-of-life care.

61 and documentation of key decisions linked to end-of-life care.

62 l were associated with perceptions of better end-of-life care.

63 We asked participants about barriers to end-of-life care (1 = huge to 5 = not at all a barrier),

64 e a number of external challenges to optimal end-of-life care: (1) geographic distance as well as pol

65 paying it forward." Scores on the Quality of End-of-Life Care-10 instrument were high.

66 cesses of care, and scores on the Quality of End-of-Life Care-10 instrument.

67 Building on ASCO's prior statements on end-of-life care (1998) and palliative care (2009), this

68 ng and promote attitudinal change concerning end-of-life care, 3) academic detailing of nurse and phy

69 the standard care group received aggressive end-of-life care (33% vs. 54%, P=0.05), median survival

70 of recovery; transition from intervention to end of life care; a controlled death.

71 of acute care, specialist and nonspecialist end-of-life care, advance care planning, and quality of

72 We compared six measures of intensity of end-of-life care among adults in the United States with

73 r diagnosis on patient-reported outcomes and end-of-life care among ambulatory patients with newly di

74 Differences in utilization and costs of end-of-life care among developed countries are of consid

75 portive care may improve quality of life and end-of-life care among patients with cancer.

76 However, little is known about end-of-life care among patients with ESRD who undergo am

77 ciated with receiving intensive and invasive end-of-life care among patients with ovarian cancer.

78 Purpose To assess disparities in end-of-life care among patients with ovarian cancer.

79 ined the relationship between amputation and end-of-life care among the patients with ESRD.

80 Discussions about the patient's wishes for end-of-life care and a greater number of spiritual care

81 can be performed successfully; its impact on end-of-life care and bereavement needs further investiga

82 or decisions made by a family with regard to end-of-life care and by assuring families continuity of

83 s can respond to an intervention to plan for end-of-life care and can express specific preferences fo

84 rdisciplinary team, involvement of nurses in end-of-life care and decision-making, active decision-ma

85 tant within this subset of patients improved end-of-life care and decreased use of superfluous resour

86 ck of educational opportunities, and gaps in end-of-life care and interprofessional teamwork.

87 Issues around end-of-life care and limitations of medical therapy aros

88 uncomfortable at the clinical juncture where end-of-life care and organ donation interface.

89 mmunication skills to improve the quality of end-of-life care and provide palliative care in the ICU.

90 gesting a mismatch between patient needs for end-of-life care and resources at participating hospital

91 The instrument included the Quality of End-of-Life Care and Satisfaction with Treatment quality

92 The convergence of end-of-life care and surgical practice often occurs in t

93 ompting national attention on the quality of end-of-life care and the development of a palliative car

94 adolescents with advanced cancer about their end-of-life care and the factors that influenced their d

95 ality evaluation by reviewing palliative and end-of-life care and the known domains for quality palli

96 the quality of ICU nurse handover related to end-of-life care and to compare the practices of differe

97 ICU directors regarding barriers to optimal end-of-life care and to identify the type, availability,

98 , perceived benefit of strategies to improve end-of-life care, and availability of these strategies.

99 Staff reported increased knowledge of end-of-life care, and enhanced confidence, which in turn

100 on-making and existing options for directing end-of-life care, and highlight important differences be

101 of homes' characteristics, the approaches to end-of-life care, and liaison with other services, was c

102 cic surgery, use of experimental treatments, end-of-life care, and limitation of care or withdrawal o

103 s, the determination of death, provisions of end-of-life care, and pediatric DCDD.

104 , neoplasm, palliative care, terminally ill, end-of-life care, and survival.

105 How socioeconomic factors influence end-of-life care, and the magnitude of their effect, is

106 ved with complications, palliative care, and end-of-life care, and thus have an important role in tea

107 gining and acting on moral possibilities for end of life care; and (E) facilitating saying goodbye -

108 fe support, high-quality decision making and end-of-life care are essential in all regions, and can i

109 n, polypharmacy, and factors associated with end-of-life care are reviewed.

110 Physicians providing end-of-life care are subject to a variety of stresses th

111 Many barriers to end-of-life care arose because of infection control prac

112 d misconceptions that palliative care meant "end-of-life care" as a major barrier, whereas transplant

113 thanasia have been increasingly discussed in end-of-life care, as PAS and euthanasia have now been le

114 impart a practical framework for quality of end-of-life care assessment with the goal of guiding the

115 will always remain an important setting for end-of-life care because of the severity of illness of p

116 ences in the utilization of life support and end-of-life care between patients dying in the medical I

117 ctors perceive important barriers to optimal end-of-life care but also universally endorse many pract

118 ication about end-of-life care or quality of end-of-life care but was associated with a small increas

119 included in national guidelines for quality end-of-life care, but little data exist to guide spiritu

120 Care Homes programme can contribute towards end-of-life care by helping to improve the quality and q

121 omes included patients' goal attainment (ie, end-of-life care congruent with patients' wishes and loc

122 End-of-life care continues even after the death of the p

123 Participating in end-of-life care conversations can be emotionally challe

124 Overcoming political divides to support end-of-life care conversations is needed to promote care

125 Less well understood is how this can inform end-of-life care decision making and complement informat

126 and should be considered in designing early end-of-life care discussions with families and patients.

127 Although they did not clearly attenuate end-of-life care disparities, medication use disparities

128 Supportive medication use did not attenuate end-of-life care disparities.

129 ues and concerns and the value of discussing end-of-life care early, with oncologists cued to endorse

130 For good end-of-life care, early communication, exploration of re

131 as to address the documented deficiencies in end-of-life care (EOLC) in intensive care unit settings

132 Eighty end-of-life care episodes were observed.

133 mmendation of prioritizing the continuity of end-of-life care, especially provider continuity, for pa

134 s to palliative care integration and optimal end-of-life care exist in this population.

135 Provider COC had a greater effect on end-of-life care expenditures than site COC did, which i

136 ue to use illicit substances while receiving end-of-life care, experts recommend scheduling frequent

137 of care and prognosis, treatment selection, end-of-life care, facilitating family involvement in car

138 nd end-of-life care (n = 3; decision making, end-of-life care, family follow-up).

139 nterhospital variability in the intensity of end-of-life care, few data are available assessing varia

140 ife care policy emphasises the importance of end of life care for all patients regardless of setting.

141 , bereaved family members reported excellent end-of-life care for 51.3%.

142 s and studies to address the gaps present in end-of-life care for cancer are necessary.

143 Five themes were identified in the data: end-of-life care for dying cancer patients, end-of-life

144 ices to preserve personalized, compassionate end-of-life care for dying hospitalized patients during

145 end-of-life care for dying cancer patients, end-of-life care for family members, cultural sensitivit

146 evidence-based HF care should be included in end-of-life care for HF patients.

147 , and evidence indicates the need to improve end-of-life care for ICU patients.

148 Conclusion End-of-life care for older patients with AML is suboptim

149 gists and hospice professionals both provide end-of-life care for oncology patients, and little has b

150 rminal hospitalization and family ratings of end-of-life care for patients who died in 106 Veterans A

151 context (LCP-I) in improving the quality of end-of-life care for patients with cancer in hospitals a

152 hich aimed to improve measures of aggressive end-of-life care for patients with cancer.

153 Recommendations to improve end-of-life care for patients with cardiovascular diseas

154 End-of-life care for patients with dementia was extremel

155 with hospice services are likely to optimise end-of-life care for patients with haematological malign

156 created positive memories and individualized end-of-life care for their loved ones.

157 f hospice services and strategies to enhance end-of-life care for these patients.

158 Few interventions have focused on improving end-of-life care for underserved populations, such as ho

159 of Life (FATE), in evaluating the quality of end-of-life care for veterans dying with cancer.

160 he commissioners modified the act to prevent end-of-life care from precluding organ donation.

161 antly more cues for discussion of prognosis, end-of-life care, future care options and general issues

162 d for transplantation received lower-quality end-of-life care, had longer hospital stays before death

163 Significant variation in resource use for end-of-life care has been observed in the US for chronic

164 The research in palliative and end-of-life care has elucidated important domains for qu

165 relatively high family satisfaction with ICU end-of-life care has prompted speculation that ICU palli

166 Quality ICU end-of-life-care has been found to be related to good co

167 Calls for improvement in end-of-life care have focused attention on the managemen

168 serve many homeless people could improve the end-of-life care homeless people receive.

169 etween race and supportive treatment use and end-of-life care (hospice, intensive care unit, more tha

170 l cancer patients to increase the quality of end-of-life care; however, limited research has been con

171 Claims-based quality measures of aggressive end-of-life care (ie, intensive care unit [ICU] admissio

172 , widowed, or divorced should be a focus for end-of-life care improvement, along with known at risk g

173 associated factors, which are essential for end-of-life care improvement.

174 expertise and develop projects that promote end-of-life care in a medical intensive care unit (ICU)

175 hose by the Institute of Medicine addressing end-of-life care in cancer and cancer survivorship.

176 End-of-life care in China reflects and has been influenc

177 tify and address local barriers to improving end-of-life care in each ICU, 4) feedback of local quali

178 sicians and surrogate decision makers around end-of-life care in ICU.

179 ies have examined the adequacy or quality of end-of-life care in institutional settings compared with

180 Initiatives to improve end-of-life care in intensive care units face several im

181 End-of-life care in nursing homes holds several risk fac

182 effective interventions to reduce aggressive end-of-life care in patients with cancer.

183 or patients, families, and clinicians during end-of-life care in the ICU are supported by eliciting a

184 It is unclear whether efforts to improve end-of-life care in the ICU could significantly reduce h

185 inally, a comprehensive agenda for improving end-of-life care in the ICU has been developed to guide

186 Therefore, improving the quality of end-of-life care in the ICU is an important endeavor.

187 are data to suggest that current quality of end-of-life care in the ICU is often poor and that this

188 onsequently, there has been speculation that end-of-life care in the ICU represents an important targ

189 tions are designed to improve the quality of end-of-life care in the ICU, researchers, clinicians, an

190 s for measuring and improving the quality of end-of-life care in the ICU.

191 merged as a comprehensive ideal for managing end-of-life care in the ICU.

192 nts and families, may improve the quality of end-of-life care in the ICU.

193 success of interventions designed to improve end-of-life care in the ICU.

194 n an attempt to create a global standard for end-of-life care in the ICU.

195 vidence suggests that change is occurring in end-of-life care in the intensive care unit (ICU).

196 ate indicators for evaluating palliative and end-of-life care in the intensive care unit, future work

197 ion is important for delivering high quality end-of-life care in the intensive care unit, yet little

198 es consistent with proficient palliative and end-of-life care in the intensive care unit.

199 fe support order form" to improve quality of end-of-life care in the intensive care unit.

200 ver, no research on interventions to improve end-of-life care in the pediatric intensive care unit (P

201 native approaches to support patient-centred end-of-life care in this population are needed.

202 summarizing existing descriptive data about end-of-life care in this setting.

203 terature reporting circumstances surrounding end-of-life care in vascular surgery patients.

204 Important barriers to better end-of-life care included patient/family factors, includ

205 Other knowledge unique to end-of-life care includes principles for notifying famil

206 and c) support for family's decisions about end- of-life care, including support for family's decisi

207 istic regressions were conducted to evaluate end-of-life care, including chemotherapy in the final 14

208 concepts play a foundational role in guiding end-of-life care, including the distinctions between wit

209 ted 14 of 14 strategies as likely to improve end-of-life care, including trainee role modeling by exp

210 Providing quality end of life care is a challenging area in intensive care

211 End of life care is often inadequate for people with dem

212 shift the patient's trajectory from cure to end of life care is required.

213 Communication about end-of-life care is a core clinical skill.

214 Improving end-of-life care is a government health priority and hom

215 End-of-life care is associated with increased burnout an

216 End-of-life care is emerging as a comprehensive area of

217 End-of-life care is frequently provided in the ICU becau

218 The provision of good quality and equitable end-of-life care is high on the public and political age

219 uld be updated to ensure that palliative and end-of-life care is in place alongside treatment should

220 End-of-life care is particularly relevant for older adul

221 in agreement with consensus statements about end-of-life care is related primarily to differences amo

222 tool for measuring and improving quality of end-of-life care, it is important to understand the fact

223 ntervention to end of life care, rather than end of life care itself so that effective and timely dec

224 who died in the hospital reported excellent end-of-life care less often (42.2% [194/460]) than those

225 U within 30 days of death reported excellent end-of-life care less often (45.0% [68/151]) than those

226 As ICUs are increasingly a site of end-of-life care, many have adopted end-of-life care res

227 led to consistent improvements in aggressive end-of-life care measures.

228 Family members reported excellent end-of-life care more often for patients who received ho

229 o patient, social and spiritual support) and end-of-life care (n = 3; decision making, end-of-life ca

230 was instrumental in drawing attention to the end-of-life care needs of patients with advanced maligna

231 ility, which affect patients' palliative and end-of-life care needs.

232 survey of providers' views on principles of end-of-life care obtained during the consensus process f

233 l provide opportunity for improvement in the end-of-life care of cancer patients.

234 pulmonology) who may also participate in the end-of-life care of potential donors in various clinical

235 he rehabilitation, complex medical care, and end-of-life care of this frail and vulnerable population

236 Supportive, palliative, and end-of-life care offer the potential to enhance quality

237 tle attention has been paid to the impact of end-of-life care on caregivers who are family members of

238 ill, evidence shows that conversations about end-of-life care options between physicians and patients

239 d not improve quality of communication about end-of-life care or quality of end-of-life care but was

240 o another acute care facility, discharged to end-of-life care, or had missing LVEF assessment status.

241 and ensures organ donation is posed at every end-of-life care pathway.

242 icle, we discuss three key drivers of costs: end-of-life care patterns, medical imaging, and drugs.

243 death and donation after circulatory death, end-of-life care, performance metrics, resources and rem

244 parental adjustment, and preparation for the end-of-life care period.

245 End-of-life care planning and decision making by health

246 d provider expectations," and "timeliness of end-of-life care planning").

247 nctional and cognitive decline, and need for end-of-life care planning.

248 der to incorporate organ donation into their end-of-life care plans.

249 End of life care policy emphasises the importance of end

250 death donors could increase with changes in end-of-life care practices to allow the evolution of bra

251 Rates of documentation of end-of-life care preferences in the medical record remai

252 , but fewer patients with PA discussed their end-of-life care preferences with their physician.

253 ationship, distress, advance directives, and end-of-life care preferences.

254 actors obtained clinical variables including end-of-life care processes and family conference data.

255 To examine end-of-life care provided to immigrants to Canada in the

256 ive and practice is truly collaborative, the end-of-life care provided to intensive care unit patient

257 Despite national efforts to improve end-of-life care, proxy reports of pain and other alarmi

258 ry outcomes were patient-reported quality of end-of-life care (QEOLC; mean rating of 26 items rated f

259 ans with families, bereavement programs, and end-of-life care quality monitoring.

260 on transition from curative intervention to end of life care, rather than end of life care itself so

261 consideration of transplantation affects the end-of-life care received by patients, care was evaluate

262 End-of-life care remains a challenging and complex activ

263 Patients admitted to ICU to manage end-of-life care represent a small proportion of overall

264 cine, and family practice that competency in end-of-life care requires specialty training.

265 ICU-based end-of-life care resources do not appear to change morta

266 site of end-of-life care, many have adopted end-of-life care resources.

267 Prevention strategies and end-of-life care services are urgently needed to prevent

268 ntial part of dignity-conserving practice in end-of-life care settings.

269 consensus provide standards of practice for end-of-life care; statements without consensus identify

270 o protect dying patients' wishes about their end-of-life care, states that have legislated or are con

271 mmunication subscale of the Self-efficacy in End-of-Life Care survey.

272 process received more intensive patterns of end-of-life care than other patients with ESKD.

273 use less life support and may receive better end-of-life care than similar patients without cancer.

274 ted with higher family ratings of quality of end-of-life care than ward care.

275 failure, little is known about the eventual end-of-life care that patients with DT-LVAD receive.

276 of the new wording creates the potential for end-of-life care that prioritizes care of the potential

277 ons associated with family disagreement over end-of-life care, the ramifications for healthcare provi

278 Ranging from primary prevention to end-of-life care, the scope for new models of care is ex

279 found among conditions, ranging from 9% for end-of-life care to 82% for stroke care.

280 e care (PC) that has evolved from a focus on end-of-life care to an expanded form of holistic care at

281 rses had strong willingness to offer quality end-of-life care to patients and families, however, they

282 spice programmes are important for providing end-of-life care to patients with life-limiting illnesse

283 Palliative medicine provides end-of-life care to terminally ill patients with a focus

284 End-of-life care varies according to the administrative

285 The transition from intervention to end of life care was reported as being the most problema

286 ith cancer in 7 developed countries in 2010, end-of-life care was more hospital-centric in Belgium, C

287 Information about end-of-life care was obtained from documentation in the

288 admission to incorporate organ donation into end-of-life care was systematically evaluated with the i

289 Advance directives specifying limitations in end-of-life care were associated with significantly lowe

290 Data on end-of-life care were collected from electronic medical

291 rvice provision of specialist palliative and end-of-life care, which have hitherto been neglected.

292 More research on how to improve end-of-life care will enable health care providers to op

293 ce of clarifying prognostic expectations and end-of-life care wishes in the advanced cancer context,

294 initiating contact and discussing residents' end-of-life care with general practitioners and those wo

295 may be useful to clinicians when discussing end-of-life care with patients and families of patients

296 st study to find a reduction in intensity of end-of-life care with similar or improved family distres

297 other indicators of potentially poor-quality end-of-life care, with evidence of a dose response indic

298 tion that palliative care is synonymous with end-of-life care, with no role earlier in the course of

299 We evaluated the predictors of quality of end-of-life care, with the main independent variable bei

300 term "palliative care," "supportive care," "end-of-life care," "withdrawal of life-sustaining therap